UA94065C2 - Dihydropseudoerythromycin derivatives - Google Patents

Dihydropseudoerythromycin derivatives

Info

Publication number
UA94065C2
UA94065C2 UAA200806366A UAA200806366A UA94065C2 UA 94065 C2 UA94065 C2 UA 94065C2 UA A200806366 A UAA200806366 A UA A200806366A UA A200806366 A UAA200806366 A UA A200806366A UA 94065 C2 UA94065 C2 UA 94065C2
Authority
UA
Ukraine
Prior art keywords
dihydropseudoerythromycin
derivatives
dihydropseudoerythromycin derivatives
compounds
salts
Prior art date
Application number
UAA200806366A
Other languages
English (en)
Ukrainian (uk)
Inventor
Сатоши Омура
Тошияки Суназука
Кеничиро Нагаи
Хидеаки Шима
Харуко Ямабе
Original Assignee
Зе Китасато Инститьют
Афиникс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зе Китасато Инститьют, Афиникс, Инк. filed Critical Зе Китасато Инститьют
Publication of UA94065C2 publication Critical patent/UA94065C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Изобретение касается соединения, представленного формулой [I], где каждый радикал является таким, как определено в описании, или его фармацевтически приемлемой соли, а также фармацевтической композиции, которая содержит соединение как активный ингредиент.[I]
UAA200806366A 2005-10-14 2006-10-13 Dihydropseudoerythromycin derivatives UA94065C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005301070 2005-10-14

Publications (1)

Publication Number Publication Date
UA94065C2 true UA94065C2 (en) 2011-04-11

Family

ID=37942921

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200806366A UA94065C2 (en) 2005-10-14 2006-10-13 Dihydropseudoerythromycin derivatives

Country Status (18)

Country Link
US (1) US8133871B2 (ru)
EP (1) EP1950219B1 (ru)
JP (1) JP5118973B2 (ru)
KR (1) KR101384927B1 (ru)
CN (1) CN101326192B (ru)
AT (1) ATE513842T1 (ru)
AU (1) AU2006300215B2 (ru)
BR (1) BRPI0617391A2 (ru)
CA (1) CA2625055C (ru)
EA (1) EA015737B1 (ru)
ES (1) ES2369898T3 (ru)
IL (1) IL190643A (ru)
MY (1) MY147211A (ru)
NZ (1) NZ567772A (ru)
PL (1) PL1950219T3 (ru)
UA (1) UA94065C2 (ru)
WO (1) WO2007043710A1 (ru)
ZA (1) ZA200803414B (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
TWI454288B (zh) 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
PT2273983T (pt) 2008-05-09 2016-10-28 Gruenenthal Gmbh Processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob utilização de uma etapa de congelamento por atomização
ES2560210T3 (es) 2009-07-22 2016-02-17 Grünenthal GmbH Forma de dosificación resistente a la manipulación para opiádes sensibles a la oxidación
CN102573805A (zh) 2009-07-22 2012-07-11 格吕伦塔尔有限公司 热熔挤出的控制释放剂型
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
TWI516286B (zh) 2010-09-02 2016-01-11 歌林達股份有限公司 含陰離子聚合物之抗破碎劑型
LT2736495T (lt) 2011-07-29 2017-11-10 Grünenthal GmbH Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
CN103857386A (zh) 2011-07-29 2014-06-11 格吕伦塔尔有限公司 提供药物立即释放的抗破碎片剂
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
CA2868142A1 (en) 2012-04-18 2013-10-24 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １個または複数の粒子を含有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
CN105682643B (zh) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
JP2018510878A (ja) * 2015-03-25 2018-04-19 プレジデント アンド フェローズ オブ ハーバード カレッジ デソサミンの合成
CN107889459A (zh) 2015-04-24 2018-04-06 格吕伦塔尔有限公司 具有立即释放和对溶剂萃取的抗性的抗篡改剂型
EP3346991A1 (en) 2015-09-10 2018-07-18 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106961A (en) * 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
PT1489090E (pt) 2000-08-17 2006-05-31 Kitasato Inst Novos derivados de pseudoeritromicina
EP1337540A2 (en) 2000-12-01 2003-08-27 Kosan Biosciences, Inc. Motilide compounds
US20020094962A1 (en) * 2000-12-01 2002-07-18 Gary Ashley Motilide compounds
US20040067896A1 (en) * 2002-07-25 2004-04-08 The Kitasato Institute Novel pseudoerythromycin derivatives
US7521428B2 (en) * 2002-10-29 2009-04-21 The Kitasato Institute Macrolide derivatives having effect of potentiating antifungal activity

Also Published As

Publication number Publication date
NZ567772A (en) 2010-07-30
JP5118973B2 (ja) 2013-01-16
EP1950219B1 (en) 2011-06-22
ES2369898T3 (es) 2011-12-07
CA2625055A1 (en) 2007-04-19
EA200801083A1 (ru) 2009-02-27
KR101384927B1 (ko) 2014-04-11
WO2007043710A9 (ja) 2007-06-07
CN101326192B (zh) 2012-06-20
KR20080064861A (ko) 2008-07-09
CN101326192A (zh) 2008-12-17
BRPI0617391A2 (pt) 2011-07-26
AU2006300215A1 (en) 2007-04-19
WO2007043710A1 (ja) 2007-04-19
IL190643A0 (en) 2008-11-03
EA015737B1 (ru) 2011-10-31
JPWO2007043710A1 (ja) 2009-07-16
CA2625055C (en) 2013-12-24
EP1950219A1 (en) 2008-07-30
IL190643A (en) 2012-03-29
EP1950219A4 (en) 2010-02-03
AU2006300215B2 (en) 2012-06-21
US8133871B2 (en) 2012-03-13
ATE513842T1 (de) 2011-07-15
PL1950219T3 (pl) 2011-11-30
ZA200803414B (en) 2009-09-30
MY147211A (en) 2012-11-14
US20090131341A1 (en) 2009-05-21

Similar Documents

Publication Publication Date Title
UA94065C2 (en) Dihydropseudoerythromycin derivatives
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
TW200744588A (en) Pharmaceutical composition for external use
MX2007010072A (es) Derivados de piperidina antibacterianos.
MY144050A (en) Tetralin and indane derivatives and uses thereof
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
TW200700393A (en) Novel cis-2,4,5-triaryl-imidazolines
WO2007061360A3 (en) Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides
MX2007003546A (es) Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa.
TNSN08407A1 (en) Organic compounds
TW200626598A (en) Pyrrazolo-pyrimidine derivatives
WO2008120725A1 (ja) 新規ピロリノン誘導体およびそれを含有する医薬組成物
SE0401971D0 (sv) Piperidne derivatives
TW200716628A (en) Novel compounds
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
MX2009006334A (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona.
WO2007099171A3 (en) Bicyclo-pyrazoles active as kinase inhibitors
TW200730510A (en) Chroman compounds
WO2007068728A3 (en) N-substituted pyrrolopyridinones active as kinase inhibitors
MX2009003169A (es) Derivados de sulfonamida.
TW200738697A (en) Benzimidazole derivatives as 5-HT6,5-HT24
WO2007018941A3 (en) Pyrimidyl-thiophene derivatives
MX2007008585A (es) Compuestos peptidicos.
WO2009075250A1 (ja) 植物病害防除剤
TW200626567A (en) Benzoxazine and quinoxaline derivatives and uses